Table 2 Detailed information on datasets included in this study
Dataset | Case/Sample | Stage | Cancer type | Data type | Treatment |
|---|---|---|---|---|---|
TCGA-LUAD | 514/569 | Early and advanced stage | LUAD | RNA-seq | Unknown |
ICGC-LUAD | 425/425 | Early and advanced stage | LUAD | RNA-seq | Unknown |
GSE31210 | 226/226 | Early stage | LUAD | RNA-seq | Unknown |
GSE72094 | 442/442 | Early and advanced stage | LUAD | RNA-seq | Unknown |
GSE50081 | 181/181 | Early stage | NSCLC | RNA-seq | Unknown |
GSE37745 | 196/196 | Unknow | NSCLC | RNA-seq | Unknown |
GSE78220 | 28/28 | Advanced stage | Melanoma | RNA-seq | Chemotherapy with Anti-PD-1 Therapy |
GSE67501 | 11/11 | Unknow | HRCC | RNA-seq | Chemotherapy with Anti-PD-1 Therapy |
GSE135222 | 27/27 | Advanced stage | NSCLC | RNA-seq | Chemotherapy with Anti-PD-L1/PD-1 Therapy |
GSE165252 | 77/77 | Unknow | ESCA | RNA-seq | Chemotherapy with Anti-PD-L1 Therapy |
IMvigor210 | 310/310 | Unknow | BUC | RNA-seq | Chemotherapy with Anti-PD-L1 Therapy |
GSE126044 | 16/16 | Unknow | NSCLC | RNA-seq | Chemotherapy with Anti-PD-1 Therapy |
GSE190265 | 34/34 | Advanced stage | NSCLC | RNA-seq | Chemotherapy with Anti-PD-L1/PD-1 Therapy |
Philip Bischoff’s study | 12/24 | Early stage | LUAD | scRNA-seq | Unknown |
GSE123902 | 14/17 | Early and advanced stage | LUAD | scRNA-seq | Unknown |
GSE131907 | 44/58 | Early and advanced stage (tLung, tL/B, mLN, and mBrain) | LUAD | scRNA-seq | Unknown |
GSE207422 | 8/8 | Early stage | NSCLC | scRNA-seq | Chemotherapy with Anti-PD-1 Therapy |
GSE189357 | 6/6 | Early stage (AIS, MIA, and IAC) | LUAD | scRNA-seq | Unknown |
GSE200563 | 35/109 | Early and advanced stage (L, mLN, and LB) | NSCLC | DSP | Unknown |
GSE189487 | 6/6 | Early stage (AIS, MIA, and IAC) | LUAD | Visium | Unknown |